Gregory J. Tsongalis, BS, MS, PhD
Professor of Pathology and Laboratory Medicine
Director, Clinical Genomics and Advanced Technology (CGAT)
Pathology and Laboratory Medicine
Univ. of Massachusetts, Amherst, BS, 1984
Quinnipiac College, MHS, 1986
Univ. of Medicine and Dentistry of New Jersey, PhD 1990
Uniiv. of North Carolina, Chapel Hill, post-doctoral 1990-1994
Norris Cotton Cancer Center
Program in Experimental and Molecular Medicine
Department of Pathology and Laboratory Medicine
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon NH 03756
Development of advanced diagnostic technologies and disease biomarker discovery.
01/2014-12/30/15; Molecular profiling of tumor and ctDNA, riends of NCCC Scholar $50,000
03/01/13-01/31/2018; 1P20GM104416, Investigator / 2% COBRE Center for Molecular Epidemiology, Federal Direct Costs: $1,793,732
Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based Testing.
Identifying aerosolized cyanobacteria in the human respiratory tract: A proposed mechanism for cyanotoxin-associated diseases.
Implementation of Multicolor Melt Curve Analysis for High-Risk Human Papilloma Virus Detection in Low- and Middle-Income Countries: A Pilot Study for Expanded Cervical Cancer Screening in Honduras.
Maternally inherited 133kb deletion of 14q32 causing Kagami-Ogata syndrome.
Identifying Associations between Somatic Mutations and Clinicopathologic Findings in Lung Cancer Pathology Reports.
Rural distribution of human papilloma virus in low- and middle-income countries.
Potential of STAT Somatic Mutation Testing at Resection.
Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing.
Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.
Somatic mutation analysis in melanoma using targeted next generation sequencing.